Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis
Patients with acute myeloid leukemia (AML) and hyperleukocytosis, defined as an initial white blood cell (WBC) count of ≥ 100 × 109/L, are often treated with leukapheresis. In this study, we have reported our experience of treating AML without leukapheresis. Methods: From November 1, 1995, to May 31...
Main Authors: | Kuan-Hao Chen, Hsi-Che Liu, Der-Cherng Liang, Jen-Yin Hou, Ting-Huan Huang, Ching-Yi Chang, Ting-Chi Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-11-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664614000114 |
Similar Items
-
Leukapheresis and Hyperleukocytosis, Past and Future
by: Zhang D, et al.
Published: (2021-07-01) -
Leukapheresis in Pediatric Acute Leukemia with Hyperleukocytosis: A Single-Center Experience
by: Sandra Renee Jones, et al.
Published: (2022-04-01) -
Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis
by: Ikhwan Rinaldi, et al.
Published: (2022-12-01) -
The value of leukapheresis for treatment of priapism as presenting feature of chronic myeloid leukemia—Case report and review of literature
by: Marleen G. A. M. van derVelde, et al.
Published: (2022-11-01) -
Emergency therapeutic leukapheresis in a case of acute myeloid leukemia M5
by: Ranganathan Sudha, et al.
Published: (2008-01-01)